Semaglutidex (Semaglumax)
Product detail for Semaglutidex, INN: semaglutidex. Therapeutic area: Metabolic. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.
Product ID
PROD-024
INN
semaglutidex
Therapeutic Area
Metabolic
Status
In Progress
Owner
Sarah Chen
Created
2022-09-09
Last Updated
2023-11-27
Markets
8
Presentations
| Form | Strength | Route |
|---|---|---|
| Inhalation powder | 5 mg/mL | Intramuscular |
| Powder for injection | 200 mg | Inhalation |
| Solution for injection | 10 mg | Topical |
| Transdermal patch | 50 mg | Transdermal |
Active Substances
| ID | Name | INN | CAS | Type | Status |
|---|---|---|---|---|---|
| SUB-001 | Kcluximab | kcluximab | 49474-41-7 | biologic | Active |
| SUB-002 | Verasenib HCl | verasenib | 20150-85-3 | biologic | Active |
Applications (3)
| Application # | Market | Procedure Type | Status | Owner | Submitted |
|---|---|---|---|---|---|
| NMPA-2021-0024 | Russia | Type IA Variation | Completed | Carlos Mendez | 2023-03-20 |
| COFEPRIS-2021-0054 | Russia | sNDA | Blocked | Marcus Webb | 2023-06-18 |
| NMPA-2021-0084 | Russia | Lifecycle Extension | Draft | Priya Sharma | 2024-01-31 |
Markets (8)